Cidara Therapeutics, Inc. (CDTX)
Jan 7, 2026 - CDTX was delisted (reason: acquired by MRK)
221.38
+0.06 (0.03%)
Inactive · Last trade price on Jan 6, 2026

Cidara Therapeutics Revenue

In the year 2024, Cidara Therapeutics had annual revenue of $1.28M, down -94.52%.

Revenue (ttm)
$1.28M
Revenue Growth
-94.52%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
38
Market Cap
6.97B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.28M-22.01M-94.52%
Dec 31, 202323.28M-213.00K-0.91%
Dec 31, 202223.50M-26.08M-52.60%
Dec 31, 202149.57M37.51M310.81%
Dec 31, 202012.07M-8.85M-42.30%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro